EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
<p><em>This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral densit...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2010-01-01
|
Series: | Вопросы современной педиатрии |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/835 |
_version_ | 1827882714022281216 |
---|---|
author | A.O. Lisitsyn E.I. Alexeeva V.G. Pinelis M.I. Bakanov S.I. Valieva T.M. Bzarova |
author_facet | A.O. Lisitsyn E.I. Alexeeva V.G. Pinelis M.I. Bakanov S.I. Valieva T.M. Bzarova |
author_sort | A.O. Lisitsyn |
collection | DOAJ |
description | <p><em>This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral density of bones, decrease of pain intensity, lessening of serum concentration of bone resorption marker — C-terminal telopeptide. The development of repeated compressive fractures of vertebrae and bones of peripheral skeleton at the time of treatment with this medication was not detected. </em><strong><em></em></strong></p><p><strong><em>Key words: children, rheumatological diseases, osteoporosis, treatment, bifosfonates, ibandronic acid.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2010;9(1):116-121)</em></span></p> |
first_indexed | 2024-03-12T19:01:39Z |
format | Article |
id | doaj.art-c91e9f067cba44f68aa7d6d5a3887529 |
institution | Directory Open Access Journal |
issn | 1682-5527 1682-5535 |
language | English |
last_indexed | 2024-03-12T19:01:39Z |
publishDate | 2010-01-01 |
publisher | "Paediatrician" Publishers LLC |
record_format | Article |
series | Вопросы современной педиатрии |
spelling | doaj.art-c91e9f067cba44f68aa7d6d5a38875292023-08-02T06:38:46Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352010-01-0191116121835EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSISA.O. Lisitsyn0E.I. Alexeeva1V.G. Pinelis2M.I. Bakanov3S.I. Valieva4T.M. Bzarova5Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow<p><em>This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral density of bones, decrease of pain intensity, lessening of serum concentration of bone resorption marker — C-terminal telopeptide. The development of repeated compressive fractures of vertebrae and bones of peripheral skeleton at the time of treatment with this medication was not detected. </em><strong><em></em></strong></p><p><strong><em>Key words: children, rheumatological diseases, osteoporosis, treatment, bifosfonates, ibandronic acid.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2010;9(1):116-121)</em></span></p>http://vsp.spr-journal.ru:80/jour/article/view/835 |
spellingShingle | A.O. Lisitsyn E.I. Alexeeva V.G. Pinelis M.I. Bakanov S.I. Valieva T.M. Bzarova EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS Вопросы современной педиатрии |
title | EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS |
title_full | EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS |
title_fullStr | EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS |
title_full_unstemmed | EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS |
title_short | EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS |
title_sort | experience of treatment with ibandronic acid in patients with severe rheumatological diseases and systemic osteoporosis |
url | http://vsp.spr-journal.ru:80/jour/article/view/835 |
work_keys_str_mv | AT aolisitsyn experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis AT eialexeeva experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis AT vgpinelis experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis AT mibakanov experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis AT sivalieva experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis AT tmbzarova experienceoftreatmentwithibandronicacidinpatientswithsevererheumatologicaldiseasesandsystemicosteoporosis |